.ANALYSIS HIGHLIGHT.06 August 2024.
A big randomized controlled trial with cisgender women highlights the problems of obedience to a regular dental preexposure prevention routine and illustrates that twice-yearly injection of lenacapavir can maintain successful HIV protection amounts over 6 months.